BioUtah COVID-19 Life Sciences Survey
March 17, 2020
TIME SENSITIVE – PLEASE TAKE SURVEY
Dear Members of Utah’s Life Sciences Community,
BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including:
- Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state
- Indentifing funding sources from state and federal governments to support emergency countermeasures and other responses
- Gaining a better understanding of how our companies are impacted and how BioUtah can provide assistance
We ask you to respond to a brief survey by Friday, March 20.
Recent News
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology
